Loading
A phase 3 trial of SYS6010 and docetaxel in lung cancer, run by CSPC Megalith Biopharmaceutical Co.,Ltd., not yet recruiting.
SYS6010 Versus Docetaxel for Previously Treated EGFR Wild-type NSCLC: Phase III is a phase 3, randomised interventional study registered as NCT07442565 by CSPC Megalith Biopharmaceutical Co.,Ltd., with a registry enrolment figure of 506 participants, started 2026-03-10 and due to reach its primary completion in 2027-12-30. Interventions recorded: SYS6010; Docetaxel. Conditions listed: Non-Small Cell Lung Cancer. Primary outcome: PFS (Progression-Free Survival) assessed by IRC (Independent Review Committee) in the EGFR high-expression population.; OS (Overall Survival) in the overall population. Lung eligibility wording from the registry: "Patients with pathologically confirmed locally advanced or metastatic EGFR wild-type non-squamous non-small cell lung cancer (nsq-NSCLC)". No results are recorded here; the registry entry is the source.
Shares SYS6010, CSPC Pharmaceutical Group, EGFR-mutated non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares SYS6010, CSPC Pharmaceutical Group, EGFR-mutated non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares SYS6010, CSPC Pharmaceutical Group, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Docetaxel, EGFR-mutated non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares SYS6010, Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares EGFR-mutated non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.